Browse By:

Search News Room

News Room: Trials

Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans

MISSION VIEJO, CA--(Marketwired - May 17, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...(more)

Aeolus Pharmaceuticals
May 17, 2013 14:19 ET

Prima BioMed Issues the Following Notice to Stockholders of the Company

SYDNEY, AUSTRALIA--(Marketwired - May 16, 2013) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") has announced in pursuant to shareholder approval...(more)

Prima BioMed
May 16, 2013 22:35 ET

Paladin présentera à la conférence de Bloom Burton à Toronto

MONTRÉAL, CANADA--(Marketwired - 16 mai 2013) - Laboratoires Paladin Inc. (TSX:PLB), chef de file de l'industrie pharmaceutique spécialisée au Canada, a annoncé aujourd'hui que son...(more)

Laboratoires Paladin Inc.
May 16, 2013 16:02 ET

Paladin Labs to Present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto

MONTREAL, CANADA--(Marketwired - May 16, 2013) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim...(more)

Paladin Labs Inc.
May 16, 2013 16:02 ET

SciClone Reports Anticipated Financial Results for the First Quarter 2013

FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported its expectations regarding financial results for the quarter ended March 31, 2013. ...(more)

SciClone Pharmaceuticals, Inc.
May 16, 2013 16:00 ET

SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market

FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company has entered into an agreement with Zensun (Shanghai) Science...(more)

SciClone Pharmaceuticals, Inc.
May 16, 2013 16:00 ET

Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting

TUSTIN, CA--(Marketwired - May 16, 2013) - Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment...(more)

Peregrine Pharmaceuticals
May 16, 2013 08:30 ET

NewLink Genetics to Be Added to NASDAQ Biotechnology Index

AMES, IA--(Marketwired - May 16, 2013) - NewLink Genetics Corporation (NASDAQ: NLNK), an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced that it has...(more)

NewLink Genetics Corporation
May 16, 2013 08:10 ET

NewLink Genetics to Present Data on Cancer Immunotherapy Programs at the ASCO 2013 Annual Meeting

AMES, IA--(Marketwired - May 16, 2013) - NewLink Genetics Corporation (NASDAQ: NLNK), an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced that several...(more)

NewLink Genetics Corporation
May 16, 2013 08:05 ET

Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace

TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today...(more)

Stem Cell Therapeutics Corp.
May 16, 2013 07:30 ET

US: 1.800.774_.9473
Canada: 1.888.299_.0338
UK: +44.20.7220_.4500

Follow Marketwired